Literature DB >> 14704836

Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance.

M Vedovato1, G Lepore, A Coracina, A R Dodesini, E Jori, A Tiengo, S Del Prato, R Trevisan.   

Abstract

AIMS/HYPOTHESIS: This study was done to measure the effect of Na+ intake on blood pressure and albuminuria, in relation with insulin sensitivity and kidney haemodynamics, in Type 2 diabetic patients with and without microalbuminuria.
METHODS: Type 2 diabetic patients, 20 with microalbuminuria, 21 without, spent two consecutive 7-day periods, one on a high (250 mmol), the other on a low-Na+ (20 mmol) diet. Body weight, 24-h blood pressure and albuminuria were measured at the end of each period. At the end of high-Na+ diet insulin sensitivity (euglycaemic insulin clamp; 2 mU.kg(-1).min(-1)) and kidney haemodynamics were measured in nine patients from each group.
RESULTS: Switching from low to high-Na+ diet resulted in an increase in blood pressure (7.4+/-4.7 mmHg; p<0.001), body weight (1.9+/-0.4 kg; p<0.05) and albuminuria [from 80 (31-183) microg/min to 101 (27-965) microg/min; p<0.01) in patients with microalbuminuria. No changes occurred in patients without microalbuminuria. Patients with microalbuminuria also had greater intraglomerular pressure (44+/-1 mmHg vs 36+/-1; p<0.001), calculated from glomerular filtration rate, renal plasma flow, plasma protein concentration and the relationship between pressure and natriuresis. In these patients insulin sensitivity was lower (5.16+/-49 vs 7.36+/-0.63 mg.kg(-1).min(-1); p=0.007). Urinary albumin excretion (r=0.40; p=0.009) and insulin sensitivity (r=-0.59; p=0.01) were correlated with intraglomerular pressure. CONCLUSION/
INTERPRETATION: High salt intake increases blood pressure and albuminuria in Type 2 diabetic patients with microalbuminuria. These responses are associated with insulin resistance and increased glomerular pressure. Insulin resistance could contribute to greater salt sensitivity, increased glomerular pressure and albuminuria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14704836     DOI: 10.1007/s00125-003-1303-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

Review 1.  Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.

Authors:  C E Mogensen
Journal:  Diabetologia       Date:  1999-03       Impact factor: 10.122

2.  Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.

Authors:  J M De'Oliveira; D A Price; N D Fisher; D R Allan; J A McKnight; G H Williams; N K Hollenberg
Journal:  Kidney Int       Date:  1997-09       Impact factor: 10.612

3.  A low-sodium diet potentiates the effects of losartan in type 2 diabetes.

Authors:  Christine A Houlihan; Terri J Allen; Amynta L Baxter; Sianna Panangiotopoulos; David J Casley; Mark E Cooper; George Jerums
Journal:  Diabetes Care       Date:  2002-04       Impact factor: 19.112

4.  Glomerular hypertension as one cause of albuminuria in type II diabetic patients.

Authors:  M Imanishi; K Yoshioka; Y Konishi; M Okumura; N Okada; T Sato; S Tanaka; S Fujii; G Kimura
Journal:  Diabetologia       Date:  1999-08       Impact factor: 10.122

5.  Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients.

Authors:  M Imanishi; K Yoshioka; M Okumura; Y Konishi; N Okada; T Morikawa; T Sato; S Tanaka; S Fujii
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

6.  Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion.

Authors:  R Trevisan; P Fioretto; A Semplicini; G Opocher; F Mantero; S Rocco; G Remuzzi; A Morocutti; G Zanette; V Donadon
Journal:  Diabetes       Date:  1990-03       Impact factor: 9.461

7.  Insulin resistance in microalbuminuric hypertension. Sites and mechanisms.

Authors:  S Bianchi; R Bigazzi; A Quiñones Galvan; E Muscelli; G Baldari; N Pecori; D Ciociaro; E Ferrannini; A Natali
Journal:  Hypertension       Date:  1995-11       Impact factor: 10.190

8.  Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria.

Authors:  R Trevisan; D Bruttomesso; M Vedovato; S Brocco; A Pianta; C Mazzon; C Girardi; E Jori; A Semplicini; A Tiengo; S Del Prato
Journal:  Diabetes       Date:  1998-08       Impact factor: 9.461

9.  Body sodium-blood volume state in nonazotemic diabetes mellitus.

Authors:  C Beretta-Piccoli; P Weidmann
Journal:  Miner Electrolyte Metab       Date:  1982-01

10.  Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.

Authors:  Carl Erik Mogensen; Giancarlo Viberti; Serge Halimi; Eberhard Ritz; Luis Ruilope; György Jermendy; Jiri Widimsky; Pinchas Sareli; Jan Taton; Juan Rull; Gürbüz Erdogan; Pieter W De Leeuw; Arthur Ribeiro; Ramiro Sanchez; Rachid Mechmeche; John Nolan; Jana Sirotiakova; Ahmed Hamani; André Scheen; Bernhard Hess; Anton Luger; Stephen M Thomas
Journal:  Hypertension       Date:  2003-03-24       Impact factor: 10.190

  10 in total
  36 in total

Review 1.  Does dietary salt increase the risk for progression of kidney disease?

Authors:  Shiraz I Mishra; Charlotte Jones-Burton; Jeffrey C Fink; Jeanine Brown; George L Bakris; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

2.  A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.

Authors:  Kalani L Raphael; Tamara Isakova; Joachim H Ix; Dominic S Raj; Myles Wolf; Linda F Fried; Jennifer J Gassman; Cynthia Kendrick; Brett Larive; Michael F Flessner; Susan R Mendley; Thomas H Hostetter; Geoffrey A Block; Ping Li; John P Middleton; Stuart M Sprague; Donald E Wesson; Alfred K Cheung
Journal:  J Am Soc Nephrol       Date:  2019-12-17       Impact factor: 10.121

3.  Kidney Function After the First Kidney Stone Event.

Authors:  William E Haley; Felicity T Enders; Lisa E Vaughan; Ramila A Mehta; Maxton E Thoman; Terri J Vrtiska; Amy E Krambeck; John C Lieske; Andrew D Rule
Journal:  Mayo Clin Proc       Date:  2016-10-21       Impact factor: 7.616

4.  Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension.

Authors:  John P Forman; Lieneke Scheven; Paul E de Jong; Stephan J L Bakker; Gary C Curhan; Ron T Gansevoort
Journal:  Circulation       Date:  2012-06-18       Impact factor: 29.690

5.  Avosentan reduces albumin excretion in diabetics with macroalbuminuria.

Authors:  René R Wenzel; Thomas Littke; Susan Kuranoff; Christiane Jürgens; Heike Bruck; Eberhard Ritz; Thomas Philipp; Anna Mitchell
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

6.  Effect of dietary salt on regulation of TGF-β in the kidney.

Authors:  Michael B Hovater; Paul W Sanders
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

7.  Dietary sodium restriction decreases urinary NGAL in older adults with moderately elevated systolic blood pressure free from chronic kidney disease.

Authors:  Wei Wang; Michel Chonchol; Douglas R Seals; Kristen L Nowak
Journal:  J Investig Med       Date:  2020-07-21       Impact factor: 2.895

8.  Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus.

Authors:  Patricia C Underwood; Bindu Chamarthi; Jonathan S Williams; Anand Vaidya; Rajesh Garg; Gail K Adler; Marissa P Grotzke; Gitana Staskus; Devendra Wadwekar; Paul N Hopkins; Claudio Ferri; Anthony McCall; Donald McClain; Gordon H Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-08-03       Impact factor: 5.958

Review 9.  Meta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on Albuminuria.

Authors:  Lanfranco D'Elia; Giovanni Rossi; Michele Schiano di Cola; Ivana Savino; Ferruccio Galletti; Pasquale Strazzullo
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-03       Impact factor: 8.237

10.  Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy.

Authors:  Klaus Burkhardt; Sonja Schwarz; Chengrui Pan; Felix Stelter; Konstantin Kotliar; Maxilian Von Eynatten; Daniel Sollinger; Ines Lanzl; Uwe Heemann; Marcus Baumann
Journal:  Cardiovasc Diabetol       Date:  2009-02-20       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.